Healthcare and Life Science
5 key considerations in connected device development
The value of a well-managed connected device can be significant, to both individuals and businesses. So, it is no surprise that the connected device ecosystem is not only thriving but growing exponentially. In fact, McKinsey global institute is estimating that connected (IoT) products ...
Source Genomics White Paper explores the transformative power of multi-omics in genomic research
Multiomics combines the various ‘omics disciplines that make up the complex landscape of life science research. With the integration of genomic, transcriptomic, proteomic and epigenomic data, we obtain an advanced vision of the overarching framework behind all phenotypic outcomes. ...
CN Bio wins ‘Most Impactful Industry Collaboration of the Year’ at the OBN Awards 2023 for ongoing research with the FDA
Six-year collaboration recognised at prestigious awards ceremony for its continued success in advancing OOC research to support widespread adoption across the pharmaceutical industry. ...
OBN (UK) Ltd shines a light on outstanding companies within the life sciences industry, at the 2023 OBN Awards, 22 November 2023, London
Abingdon, UK – OBN (UK) Ltd., the not-for-profit membership organisation that catalyses growth for the life sciences industry, is delighted to announce the winners of their 2023 OBN Awards, presented at the Royal Lancaster, London, on Wednesday 22 November. ...
Unleashing the potential of Micro 3D Printing with the BMF PµSL System
IPFL is at the forefront of micro 3D printing innovation with the BMF PµSL system, offering unparalleled precision in manufacturing microscale components. Ideal for aerospace, medical, and electronics industries, this advanced technology enables the creation of highly detailed parts pre...
Broken String Biosciences appoints Gavin Burns as Vice President of Quality and Operations
Cambridge, UK: Broken String Biosciences, a genomics company that has built a technology platform to drive the development of cell and gene therapies that are safer by design, announces the appointment of Gavin Burns, PhD, as Vice President of Quality and Operations. ...
3 Steps for cell & gene therapy medical affairs teams to provide strategic value
A phrase often recited within the pharmaceutical and biotechnology industries in recent years is that medical affairs is the third strategic pillar of success, along with R&D and commercial. Ongoing advancements in the cell and gene therapy sector have further highlighted the critic...
Yourgene Health becomes a PacBio Compatible Partner: enabling PacBio customers to optimise size selection for long-read sequencing libraries
Yourgene’s LightBench® instrument offers precise and accurate size selection of PacBio® SMRTbell® sequencing libraries increasing HiFi sequencing yields ...
First product incorporating Arecor’s Arestat Technology, AT220, launches in Europe
First commercial sale triggers milestone payment and future royalties to Arecor
The Paradigm Shift: Navigating the emergence of value-based contracts for future gene therapies
Value-based contracting (VBC) has been difficult to execute in the pharmaceutical arena, especially in the gene therapy space. This has been driven by several factors, including the lack of long-term data, the imbalance of upside and downside risk between manufacturers and payers, and d...